Efficacy and safety of continuous midazolam infusion in the treatment of acute repetitive seizures in non‐intensive settings: A multicenter retrospective real‐world data study
Epilepsia · 2026-05 · 67 (5)
DOI: 10.1002/epi.70180 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Epilepsia, online erschienen am 06.03.2026. Verfasst von Alessandro Orsini und 18 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. Hauptthemen laut MEDLINE: Midazolam, Anticonvulsants, Seizures, Status Epilepticus. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Seizures, when prolonged or repeated, leading to status epilepticus (SE), represent a medical emergency, requiring prompt treatment. In these conditions, the use of continuous midazolam (MDZ) infusion is often reserved for established or refractory SE and considered an anesthesiologic treatment, while evidence on its early use in non‐intensive settings is still limited. To verify this approach in daily practice, we retrospectively collected data on about 42 episodes of pediatric SE or acute repetitive seizures (ARSs), treated with continuous MDZ infusion in non‐intensive setting. Collected data include demographical information, previous history of epilepsy, instrumental examinations (electroencephalography [EEG] and brain magnetic resonance imaging [MRI]), comorbidities, anti‐seizure medications (ASMs), information about the event, other treatments (first‐ and second‐line), information about MDZ infusion, and need for other third‐line treatment and/or intensive care unit (ICU) transfer. Infusion durations and rates varied widely, but in most cases (38/42) low dose (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Neurology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
- IRCCS Istituto delle Scienze Neurologiche di Bologna, U.O.C. Neuropsichiatria dell'età pediatrica, Full Member of the ERN EpiCare, Bologna, Italy.
- Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum - University of Bologna, Bologna, Italy.
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Clinica Pediatrica, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
- U.O.C. Pediatria, Ospedale Sant'Anna, Como, Italy.
ORCID-Profile: Alessandro Orsini, Lorenza Marini, Luca Bergonzini, Thomas Foiadelli, Viola Santi, Alberto Verrotti, Alessandro Ferretti, Pasquale Parisi, Riccardo Morganti, Beate Küppers, Alice Bonuccelli, Roberta Battini, Diego Peroni, Duccio Maria Cordelli
Zitieren
APA
Orsini, A., Marini, L., Bergonzini, L., D'Angelo, F., Lelli, S., Foiadelli, T., Spreafico, E., Santi, V., Mencaroni, E., Verrotti, A., Ferretti, A., Parisi, P., Morganti, R., De Lorenzo, B., Küppers, B., Bonuccelli, A., Battini, R., Peroni, D., & Cordelli, D. M. (2026). Efficacy and safety of continuous midazolam infusion in the treatment of acute repetitive seizures in non‐intensive settings: A multicenter retrospective real‐world data study. Epilepsia, 67(5). https://doi.org/10.1002/epi.70180
Vancouver
Orsini A, Marini L, Bergonzini L, D'Angelo F, Lelli S, Foiadelli T, et al. Efficacy and safety of continuous midazolam infusion in the treatment of acute repetitive seizures in non‐intensive settings: A multicenter retrospective real‐world data study. Epilepsia. 2026;67(5). doi:10.1002/epi.70180
BibTeX
@article{Orsini2026,
author = {Orsini, Alessandro and Marini, Lorenza and Bergonzini, Luca and D'Angelo, Francesco and Lelli, Silvia and Foiadelli, Thomas and Spreafico, Eugenia and Santi, Viola and Mencaroni, Elisabetta and Verrotti, Alberto and Ferretti, Alessandro and Parisi, Pasquale and Morganti, Riccardo and De Lorenzo, Brita and Küppers, Beate and Bonuccelli, Alice and Battini, Roberta and Peroni, Diego and Cordelli, Duccio Maria},
title = {Efficacy and safety of continuous midazolam infusion in the treatment of acute repetitive seizures in non‐intensive settings: A multicenter retrospective real‐world data study},
journal = {Epilepsia},
year = {2026},
volume = {67},
number = {5},
doi = {10.1002/epi.70180}
}
EUVIMED